Background: The basic cellular components of proliferative vitreoretinopathy (PVR) membranes are well studied. Endothelial cells have also been documented. The importance of the vascular element in PVR has received little attention, as vascular components are clinically inapparent. The aim of this study was to obtain a better characterization and quantification of occurrence of the vascular component.
Methods: Serial sections of surgically excised PVR membranes were examined with Lectin histochemistry (25 membranes with ulex europaeus agglutinin I [UEA I] and rhicinus communis agglutinin I [RCA I]), immunohistochemistry for von Willebrand factor (31 membranes), and electron microscopy.
Results: Vascular endothelial cells were identified by visualization of UEA I and RCA I binding sites or by marking for von Willebrand factor. A total of 28.6% of the PVR membranes showed a vascular component. Vascular components consisted mostly of capillary-sized vessels; larger vessels were rarely found. Ultrastructurally, most vascular elements were found to be capillaries of the nonfenestrated type. Membranes from eyes that underwent PVR surgery with silicone oil tamponade showed vascular components less frequently (18.5%) than did membranes from eyes without silicone oil (43.8%).
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1097/00006982-199801000-00010 | DOI Listing |
Free Radic Biol Med
January 2025
Tianjin Key Laboratory of Retinal Functions and Diseases, Tianjin Branch of National Clinical Research Center for Ocular Disease, Eye Institute and School of Optometry, Tianjin Medical University Eye Hospital, Tianjin, P. R. China, No.251 Fu Kang Road, Nankai District, Tianjin 300384, P. R. China. Electronic address:
Proliferative vitreoretinopathy (PVR) is a major cause of rhegmatogenous retinal detachment repair failure. Despite many attempts to find therapeutics for PVR, no pharmacotherapy has been proven effective. Steroids, as the epitome, show uncertain clinical effectiveness, which lacks an explanation and hints at unappreciated mechanisms of PVR.
View Article and Find Full Text PDFEndocr Metab Immune Disord Drug Targets
January 2025
Department of Laboratory Medicine, Taizhou First People's Hospital, Huangyan Hospital of Wenzhou Medical University, Taizhou, Zhejiang, China.
Aim: The aim of this study is to examine the role of the microrchidia (MORC) family, a group of chromatin remodeling proteins, as the therapeutic and prognostic markers for colorectal cancer (CRC).
Background: MORC protein family genes are a highly conserved nucleoprotein superfamily whose members share a common domain but have distinct biological functions. Previous studies have analyzed the roles of MORCs as epigenetic regulators and chromatin remodulators; however, the involvement of MORCs in the development and pathogenesis of CRC was less examined.
Ann Thorac Surg Short Rep
December 2024
Institute for Integrated Life Skills, LLC, Bermuda Run, North Carolina.
Background: The expanded polytetrafluoroethylene (ePTFE) valved conduit (VC) has been reported for pulmonary valve replacement (PVR). The purpose of this study was to review long-term outcomes of our trileaflet ePTFE VC.
Methods: This multicenter study was performed with institutional review board approval from each institution.
Ann Thorac Surg Short Rep
June 2024
Department of Cardiothoracic Surgery and Perfusion Services, The Heart Center, Nationwide Children's Hospital, Columbus, Ohio.
Background: Right ventricular (RV) failure after heart transplantation (HT) is common in those with pretransplantation elevated pulmonary vascular resistance (PVR). Mechanical circulatory support has been used as a bridge to recovery, with mixed outcomes. We describe a patient with failed single-ventricle palliation in whom severe RV failure developed after HT.
View Article and Find Full Text PDFJ Transl Med
December 2024
Department of Cancer Diagnosis and Treatment Center, Affiliated Hospital of Jiangnan University, Wuxi, China.
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!